Status:

TERMINATED

High Energy Density Pulse Electromagnetic Field for Patients With Frozen Shoulder

Lead Sponsor:

Tri-Service General Hospital

Conditions:

Frozen Shoulder

Eligibility:

All Genders

20-75 years

Phase:

NA

Brief Summary

The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with frozen shoulder

Detailed Description

Frozen shoulder causes shoulder pain and limited range of motion(ROM). It is thought to afflict between 2 and 5% of the general population. Individuals of middle age are most often affected, typically...

Eligibility Criteria

Inclusion

  • Frozen shoulder is diagnosed by physicians based on the patient's medical history, physical examination, X-ray, and ultrasound reports.
  • The symptoms persist for more than 3 months.
  • There is a reduction of at least 30 degrees in at least two of the affected shoulder joint angles compared to the angles of the healthy side: shoulder flexion, abduction, and external rotation.

Exclusion

  • Shoulder musculoskeletal ultrasound reveals a full-thickness tear or massive tear of the shoulder rotator cuff tendons or calcific tendinitis.
  • Systemic rheumatic disease.
  • History of shoulder fracture or previous surgical treatment of the shoulder joint.
  • Acute cervical nerve root compression.
  • Patients with instability (e.g., those with symptoms of internal bleeding) or cancer patients.
  • Received shoulder injections for treatment within the past 3 months.
  • Impaired cognitive function that prevents the patient from providing informed consent or participating in rehabilitation therapy.
  • Pregnant or breastfeeding women.
  • Meets any of the contraindications for high-energy electromagnetic pulse therapy: organ transplant recipients; individuals with implanted cardiac pacemakers, defibrillators, metal implants (such as stents), cochlear implants, and insulin supplementation.

Key Trial Info

Start Date :

October 31 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2024

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT05979974

Start Date

October 31 2023

End Date

November 30 2024

Last Update

January 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tri-service general hospital

Taipei, Taiwan